Literature DB >> 16521692

Fetal hemolytic anemia associated with maternal sulfasalazine therapy during pregnancy.

Hans Bokström1, Rose-Marie Holst, Ola Hafström, Birgitta Swolin, Mari Louise Johansson, Gertrud Brunlöf, Thomas Hedner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16521692     DOI： 10.1080/00016340500334810

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN： 0001-6349            Impact factor:   3.636


× No keyword cloud information.
  3 in total

1.  Effects and treatment of inflammatory bowel disease during pregnancy.

Authors:  Harvinder Brar; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2008-07       Impact factor: 3.275

Review 2.  Management of rheumatoid arthritis during pregnancy: challenges and solutions.

Authors:  Megan L Krause; Ashima Makol
Journal:  Open Access Rheumatol       Date:  2016-03-23

3.  Mesalazine as a cause of fetal anemia and hydrops fetalis: A case report.

Authors:  Sverker Ek; Staffan Rosenborg
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.